Connect with us
Eli Lilly's first-quarter results exceeded expectations, with a $8.77 billion turnover, a 26% year-on-year growth, and $2.24 billion net income, 67% higher than in 2023. Strong...
Laminar Pharma, founded by Professor Pablo Vicente Escribá, seeks to raise €7 million for its drug trial, LAM561, targeting glioblastoma. With phase III trials underway in...
Bioprinting, once hailed for its potential to print human organs and tissues, took a backseat after the pandemic. However, with an estimated market value of $1.44...
Merck invests over 300 million euros in a new biotech research center in Germany, part of a larger 1.5 billion euro investment program for Darmstadt. The...
MSD closed 2023 with a turnover of 55.5 billion euros, 1% more than in 2022, when it obtained sales of 54.7 billion euros. The pharmaceutical company...
PharmaMar's profits rebound with a 64% increase to 2.3 million euros in Q1 2024 compared to the same period last year. Total revenues dropped by 19.45%...
Grifols reports positive results from its Phase IV study of Fanhdi for von Willebrand disease (VWD) treatment, showing safety and efficacy. Presented at the 2024 World...
Vithas and MSD have formed an alliance to enhance patient care, especially in cancer treatment. The collaboration focuses on innovation, research, and education, coinciding with the...
In 2022, spending on biotechnology Research and Development (R&D) increased by 13% to reach 2.56 billion euros. Company expenditure grew by 17.8%, accounting for 47.7% of...
The AI boom extends to mental health, with startups emerging in Spain aiming to leverage technology for patient and professional benefits. Solutions like MoodCapture detect mental...